In Japan, 2,8 million people suffer from atopic dermatitis, 10 million in the US.
AnGes MG press release, April 17, 2013
Shionogi and AnGes MG start phase I of NF-κB decoy oligo A, directed towards atopic dermatitis
In Japan, 2,8 million people suffer from atopic dermatitis, 10 million in the US.
AnGes MG press release, April 17, 2013